121 related articles for article (PubMed ID: 29247685)
1. Comparison among different "revealers" in the study of accelerated blood clearance phenomenon.
Liang K; Wang L; Su Y; Liu M; Feng R; Song Y; Deng Y
Eur J Pharm Sci; 2018 Mar; 114():210-216. PubMed ID: 29247685
[TBL] [Abstract][Full Text] [Related]
2. Accelerated Blood Clearance of Nanoemulsions Modified with PEG-Cholesterol and PEG-Phospholipid Derivatives in Rats: The Effect of PEG-Lipid Linkages and PEG Molecular Weights.
Liu M; Chu Y; Liu H; Su Y; Zhang Q; Jiao J; Liu M; Ding J; Liu M; Hu Y; Dai Y; Zhang R; Liu X; Deng Y; Song Y
Mol Pharm; 2020 Apr; 17(4):1059-1070. PubMed ID: 31860321
[TBL] [Abstract][Full Text] [Related]
3. PEGylated nanoemulsions containing 1,2-distearoyl-sn-glycero-3-phosphoglycerol induced weakened accelerated blood clearance phenomenon.
Li Z; Gao X; Yan X; Deng Y; Ma H
Drug Deliv Transl Res; 2022 Oct; 12(10):2569-2579. PubMed ID: 35094294
[TBL] [Abstract][Full Text] [Related]
4. Use of polyglycerol (PG), instead of polyethylene glycol (PEG), prevents induction of the accelerated blood clearance phenomenon against long-circulating liposomes upon repeated administration.
Abu Lila AS; Nawata K; Shimizu T; Ishida T; Kiwada H
Int J Pharm; 2013 Nov; 456(1):235-42. PubMed ID: 23928149
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the Accelerated Blood Clearance Phenomenon of PEGylated Nanoemulsions in Rats by Intraperitoneal Administration.
Su Y; Liu M; Liang K; Liu X; Song Y; Deng Y
AAPS PharmSciTech; 2018 Oct; 19(7):3210-3218. PubMed ID: 30187444
[TBL] [Abstract][Full Text] [Related]
6. Repeated injection of PEGylated solid lipid nanoparticles induces accelerated blood clearance in mice and beagles.
Zhao Y; Wang L; Yan M; Ma Y; Zang G; She Z; Deng Y
Int J Nanomedicine; 2012; 7():2891-900. PubMed ID: 22745552
[TBL] [Abstract][Full Text] [Related]
7. Hemoglobin vesicles, polyethylene glycol (PEG)ylated liposomes developed as a red blood cell substitute, do not induce the accelerated blood clearance phenomenon in mice.
Taguchi K; Urata Y; Anraku M; Watanabe H; Kadowaki D; Sakai H; Horinouchi H; Kobayashi K; Tsuchida E; Maruyama T; Otagiri M
Drug Metab Dispos; 2009 Nov; 37(11):2197-203. PubMed ID: 19679674
[TBL] [Abstract][Full Text] [Related]
8. Effects of Uncleavable and Cleavable PEG-Lipids with Different Molecular Weights on Accelerated Blood Clearance of PEGylated Emulsions in Beagle Dogs.
Jiao J; Luo X; Wang C; Jiao X; Liu M; Liu X; Wei L; Deng Y; Song Y
AAPS PharmSciTech; 2020 Mar; 21(3):106. PubMed ID: 32185548
[TBL] [Abstract][Full Text] [Related]
9. Influence of phospholipid types and animal models on the accelerated blood clearance phenomenon of PEGylated liposomes upon repeated injection.
Xu H; Ye F; Hu M; Yin P; Zhang W; Li Y; Yu X; Deng Y
Drug Deliv; 2015; 22(5):598-607. PubMed ID: 24524364
[TBL] [Abstract][Full Text] [Related]
10. Phospholipidosis assay in HepG2 cells and rat or rhesus hepatocytes using phospholipid probe NBD-PE.
Bhandari N; Figueroa DJ; Lawrence JW; Gerhold DL
Assay Drug Dev Technol; 2008 Jun; 6(3):407-19. PubMed ID: 18537465
[TBL] [Abstract][Full Text] [Related]
11. Topical drug delivery to retinal pigment epithelium with microfluidizer produced small liposomes.
Lajunen T; Hisazumi K; Kanazawa T; Okada H; Seta Y; Yliperttula M; Urtti A; Takashima Y
Eur J Pharm Sci; 2014 Oct; 62():23-32. PubMed ID: 24810393
[TBL] [Abstract][Full Text] [Related]
12. Surface decorated nanoparticles as surrogate carriers for improved transport and absorption of epirubicin across the gastrointestinal tract: Pharmacokinetic and pharmacodynamic investigations.
Tariq M; Alam MA; Singh AT; Panda AK; Talegaonkar S
Int J Pharm; 2016 Mar; 501(1-2):18-31. PubMed ID: 26812610
[TBL] [Abstract][Full Text] [Related]
13. Mixed PEGylated surfactant modifying system decrease the accelerated blood clearance phenomenon of nanoemulsions in rats.
Su Y; Tang W; Song Y; Wang C; Tian Q; Wang X; Quan J; Li B; Wang S; Deng Y
Asian J Pharm Sci; 2017 Jan; 12(1):28-36. PubMed ID: 32104311
[TBL] [Abstract][Full Text] [Related]
14. Denatured globular protein and bile salt-coated nanoparticles for poorly water-soluble drugs: Penetration across the intestinal epithelial barrier into the circulation system and enhanced oral bioavailability.
He W; Yang K; Fan L; Lv Y; Jin Z; Zhu S; Qin C; Wang Y; Yin L
Int J Pharm; 2015 Nov; 495(1):9-18. PubMed ID: 26325310
[TBL] [Abstract][Full Text] [Related]
15. Spleen plays an important role in the induction of accelerated blood clearance of PEGylated liposomes.
Ishida T; Ichihara M; Wang X; Kiwada H
J Control Release; 2006 Oct; 115(3):243-50. PubMed ID: 17011060
[TBL] [Abstract][Full Text] [Related]
16. Time Interval of Two Injections and First-Dose Dependent of Accelerated Blood Clearance Phenomenon Induced by PEGylated Liposomal Gambogenic Acid: The Contribution of PEG-Specific IgM.
Wang F; Ye X; Wu Y; Wang H; Sheng C; Peng D; Chen W
J Pharm Sci; 2019 Jan; 108(1):641-651. PubMed ID: 30595169
[TBL] [Abstract][Full Text] [Related]
17. Progress in the development of lipopolyplexes as efficient non-viral gene delivery systems.
Rezaee M; Oskuee RK; Nassirli H; Malaekeh-Nikouei B
J Control Release; 2016 Aug; 236():1-14. PubMed ID: 27317365
[TBL] [Abstract][Full Text] [Related]
18. Accelerated blood clearance was not induced for a gadolinium-containing PEG-poly(L-lysine)-based polymeric micelle in mice.
Ma H; Shiraishi K; Minowa T; Kawano K; Yokoyama M; Hattori Y; Maitani Y
Pharm Res; 2010 Feb; 27(2):296-302. PubMed ID: 20035375
[TBL] [Abstract][Full Text] [Related]
19. Accelerated blood clearance phenomenon upon cross-administration of PEGylated nanocarriers in beagle dogs.
Wang C; Cheng X; Su Y; Pei Y; Song Y; Jiao J; Huang Z; Ma Y; Dong Y; Yao Y; Fan J; Ta H; Liu X; Xu H; Deng Y
Int J Nanomedicine; 2015; 10():3533-45. PubMed ID: 25999716
[TBL] [Abstract][Full Text] [Related]
20. Enhanced Opsonization-Independent Phagocytosis and High Response Ability to Opsonized Antigen-Antibody Complexes: A New Role of Kupffer Cells in the Accelerated Blood Clearance Phenomenon upon Repeated Injection of PEGylated Emulsions.
Cheng X; Wang C; Su Y; Luo X; Liu X; Song Y; Deng Y
Mol Pharm; 2018 Sep; 15(9):3755-3766. PubMed ID: 30044914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
